588 / 1631
POD 24
•
Abstract 0412: Validation of POD24 As a
Robust Early Clinical Endpoint of Poor
Survival in Follicular Lymphoma: Results
from the Follicular Lymphoma Analysis of
Surrogacy Hypothesis (FLASH)
Investigation Using Individual Data from
5,453 Patients on 13 Clinical Trials